{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:06:36Z","timestamp":1791410796157,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ijrobp.2015.12.010","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T20:00:56Z","timestamp":1450900856000},"page":"1043-1051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer"],"prefix":"10.1016","volume":"94","clinical-trial-number":[{"clinical-trial-number":"nct01409473","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01856855","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01976962","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02145494","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hima Bindu","family":"Musunuru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Vesprini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mamedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D'Alimonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Commisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Helou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Deabreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Loblaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.12.010_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.clon.2015.01.011","article-title":"Stereotactic body radiation therapy for prostate cancer","volume":"27","author":"Henderson","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijrobp.2014.08.006","article-title":"Role of the technical aspects of hypofractionated radiation therapy treatment of prostate cancer: A review","volume":"91","author":"Clemente","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib3","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiation therapy outcomes of 5,969 patients in seven international institutional datasets: Alpha\/beta = 1.4 (0.9-2.2) gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00384-013-1784-8","article-title":"Systematic review: Anal and rectal changes after radiation therapy for prostate cancer","volume":"29","author":"Krol","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","article-title":"Gastrointestinal radiation injury: Symptoms, risk factors and mechanisms","volume":"19","author":"Shadad","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2009.09.004","article-title":"Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: Results of a large multicenter observational study","volume":"93","author":"Fellin","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.clon.2011.03.001","article-title":"The impact of clinical factors on the development of late radiation toxicity: Results from the medical research council RT01 trial (ISRCTN47772397)","volume":"23","author":"Barnett","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijrobp.2004.12.052","article-title":"Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy","volume":"62","author":"Vargas","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2014.10.014","article-title":"Rectal toxicity after intensity modulated radiotherapy for prostate cancer: Which rectal dose volume constraints should we use?","volume":"113","author":"Fonteyne","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2010.09.058","article-title":"Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: An exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity","volume":"82","author":"Pederson","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fonc.2014.00336","article-title":"A phase II study of stereotactic body radiation therapy for low-intermediate-high-risk prostate cancer using helical tomotherapy: Dose-volumetric parameters predicting early toxicity","volume":"4","author":"Macias","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.prro.2015.01.006","article-title":"Dosimetric parameters predict short-term quality-of-life outcomes for patients receiving stereotactic body radiation therapy for prostate cancer","volume":"5","author":"Gomez","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13014-014-0277-4","article-title":"Proctitis following stereotactic body radiation therapy for prostate cancer","volume":"9","author":"Joh","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2014.06.009","article-title":"Dosimetric and patient correlates of quality of life after prostate stereotactic ablative radiotherapy","volume":"112","author":"Elias","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fonc.2014.00313","article-title":"Evolution of hypofractionated accelerated radiotherapy for prostate cancer\u2014The Sunnybrook experience","volume":"4","author":"Musunuru","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(03)00132-9","article-title":"What hypofractionated protocols should be tested for prostate cancer?","volume":"56","author":"Fowler","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.clon.2011.12.001","article-title":"Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging","volume":"24","author":"Quon","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(97)00234-4","article-title":"Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales","volume":"38","author":"Hanlon","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/00401706.1972.10488991","article-title":"Theory and applications of hazard plotting for censored failure data","volume":"14","author":"Nelson","year":"1972","journal-title":"Technometrics"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2013.03.022","article-title":"Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes","volume":"107","author":"Loblaw","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ijrobp.2007.07.2363","article-title":"Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer","volume":"70","author":"van der Laan","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2217\/fon.15.14","article-title":"Clinical trials of stereotactic ablative radiotherapy for prostate cancer: Updates and future direction","volume":"11","author":"Musunuru","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13014-014-0262-y","article-title":"Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)","volume":"9","author":"Gladwish","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib24","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1016\/j.ijrobp.2015.07.1108","article-title":"Phase 1-2 study of stereotactic ablative radiation therapy including regional lymph node irradiation for patients with high-risk prostate cancer (SATURN)","volume":"93","author":"Musunuru","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/1754-9485.12213","article-title":"Stereotactic body radiotherapy for primary prostate cancer: A systematic review","volume":"58","author":"Tan","year":"2014","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib26","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1016\/j.ijrobp.2015.07.1038","article-title":"Low-dose-rate prostate brachytherapy is superior to dose-escalated EBRT for unfavorable risk prostate cancer: The results of the ASCENDE-RT randomized control trial","volume":"93","author":"Rodda","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jrr\/rru048","article-title":"Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using cyberknife","volume":"55","author":"Fukuda","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brachy.2014.11.005","article-title":"Late rectal toxicity after low-dose-rate brachytherapy: Incidence, predictors, and management of side effects","volume":"14","author":"Kishan","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2004.04.014","article-title":"Fractionation and late rectal toxicity","volume":"60","author":"Brenner","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.03.012","article-title":"Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2009.02.026","article-title":"External beam radiotherapy for prostate cancer patients on anticoagulation therapy: How significant is the bleeding toxicity?","volume":"76","author":"Choe","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ijrobp.2012.10.042","article-title":"Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer","volume":"85","author":"Hamstra","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","article-title":"Dose-volume effects for normal tissues in external radiotherapy: Pelvis","volume":"93","author":"Fiorino","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature","volume":"61","author":"Budaus","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.gtc.2013.08.004","article-title":"Management of radiation proctitis","volume":"42","author":"Sarin","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MIB.0000000000000227","article-title":"Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis","volume":"21","author":"Wu","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib37","first-page":"A7698","volume":"158","author":"van Roermund","year":"2014","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-015-0426-4","article-title":"Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated stereotactic ablative body radiotherapy (SABR)","volume":"10","author":"Nicolae","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2014.11.027","article-title":"Prostate hypofractionated radiation therapy with injection of hyaluronic acid: Acute toxicities in a phase 2 study","volume":"91","author":"Chapet","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.12.010_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2015.04.008","article-title":"Relation between ku80 and microrna-99a expression and late rectal bleeding after radiotherapy for prostate cancer","volume":"115","author":"Someya","year":"2015","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615268472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615268472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T12:29:21Z","timestamp":1537100961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615268472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0360301615268472"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.12.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}